ArticleHealth science reports2025
Neurocardiology Update: The Brain-Heart Connection in Multiple Sclerosis-A Narrative Review.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: While multiple sclerosis (MS) is primarily considered a neurological disorder, mounting evidence suggests a strong association with cardiovascular diseases (CVDs), impacting both disease progression and patient outcomes. This paper aims to raise awareness of this disease association while promoting a clinical-oriented, multidisciplinary approach that can provide long-term benefits for these patients. Methods: A comprehensive literature review was conducted to gather up-to-date evidence concerning the incidence and type of CVDs associated with MS, the mechanisms underlying this disease association, as well as the impact on MS progression. Based on this evidence, a neurocardiological approach to MS in clinical practice was proposed. Results: Past and present research agree on the high rates of arterial hypertension, metabolic syndrome, stroke, and myocardial infarction in people with MS. However, other prevalent comorbidities, such as venous thromboembolism and autonomic dysfunction may be easily overlooked in clinical practice. A complex interplay between genetic predisposition, traditional risk factors, autonomic dysfunction, inflammation, and treatment-related factors likely plays a role in promoting CVDs in MS. The impact of cardiovascular dysfunction on MS progression ranges from subclinical impairments, such as impaired axonal repairing, to overt physical disability and cognitive dysfunction. This paper proposes a neurocardiological approach to the daily clinical practice of MS patients, comprising general lifestyle measures, comorbidity screening at MS diagnosis, extensive work-ups for progressive/active forms, and selected autonomic dysfunction screening. Conclusion: MS is a lifelong disorder that can be associated with a multitude of comorbidities, particularly cardiovascular ones. Along with increased mortality, cardiovascular pathology can adversely affect clinical and radiological-derived MS outcomes. Thus, surveillance and preventative measures are required for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.